<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01007006</url>
  </required_header>
  <id_info>
    <org_study_id>07247003</org_study_id>
    <secondary_id>W81XWH-09-1-0092</secondary_id>
    <nct_id>NCT01007006</nct_id>
  </id_info>
  <brief_title>Telepharmacy Robotic Medicine Delivery Unit &quot;TRMDU&quot; Assessment</brief_title>
  <official_title>Evaluation of a Telepharmacy Robotic Medicine Delivery Unit in Warrior Transition Unit Patients With Traumatic Brain Injury, Post-Traumatic Stress Disorder, or Polytrauma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. Army Medical Research and Materiel Command</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate whether use of TRMDU in addition to medication
      review leads to improved outcomes and reduced health care costs for patients when compared
      with medication review alone. The study will be conducted in patients assigned to Department
      of Defense (DOD) Warrior Transition Units (WTU's), similar DOD units, and VA polytrauma
      centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The military has been witnessing an increased number of patients with combat related
      impairments such as traumatic brain injury, post traumatic stress disorder and polytrauma
      which has lead to sub optimal medication self management. TRMDU is a medical device developed
      by INRange Systems Inc. that delivers medications and emits a sound alert to assist the
      patient. It can be used in a hospital, clinic, or residential setting. It can be remotely
      accessed by the health care professionals, and it allows physicians and other prescribers to
      remotely change scheduling or adjust prescriptions.

      Use of TRMDU in hospital settings is expected to improve outcomes by improving medication
      self management, increasing adherence, reducing medication errors, and thereby associated
      costs. Further, it may contribute to overall improvement in a patient's psychological
      well-being and quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">June 2011</completion_date>
  <primary_completion_date type="Anticipated">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adherence as measured by pill counts and self report (Morisky 8-item)</measure>
    <time_frame>Baseline, one, two and three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain, psychological well-being, health related quality of life, cost</measure>
    <time_frame>Baseline, one, two, three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">165</enrollment>
  <condition>Traumatic Brain Injury</condition>
  <condition>Posttraumatic Stress Disorders</condition>
  <condition>Trauma</condition>
  <condition>Combat Disorders</condition>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>TMRDU</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Telepharmacy Robotic Medicine Delivery Unit (TMRDU) group will receive TMRDU plus medication management</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control arm will receive only medication management, no TMRDU.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TMRDU</intervention_name>
    <description>The TMRDU will assist study subjects with taking their medications as prescribed by notifying them when the next dose is due and tracking whether and when it was taken.</description>
    <arm_group_label>TMRDU</arm_group_label>
    <other_name>Electronic Medication Management Assistant, (EMMA) (R)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Subjects must be

          -  At least 18 years of age

          -  Alert and oriented to person , place and time

          -  Primarily use English language for written and oral communication

          -  Have diagnosis of Traumatic Brain Injury(TBI) Multiple Traumatic Brain Injury (MTBI),
             Post Traumatic Stress Disorder (PTSD) or Polytrauma.

          -  Taking at least 4 chronic prescription medications

          -  Living in a participating WTU or enrolled in Tampa Veterans Administration polytrauma
             outpatient treatment facility at the time of enrollment

          -  Achieve a minimum score of 24 on Mini-Mental State Examination

        Exclusion Criteria: If patients meet following criteria they are excluded from the study

          -  Disabilities preventing safe use of the TRMDU

          -  Projected life expectancy of less than 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel R Touchette, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Illinois at Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jill M Winters, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Columbia College of Nursing</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daniel R Touchette, Pharm.D., MA</last_name>
    <phone>3123553204</phone>
    <email>drtouche@uic.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jill M Winters, PhD</last_name>
    <phone>4149614202</phone>
    <email>jwinters@ccon.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Naval Hospital Camp Pendleton</name>
      <address>
        <city>Camp Pendleton</city>
        <state>California</state>
        <zip>92055</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caine Kras, Pharm D</last_name>
      <phone>760-725-3278</phone>
      <email>caine.kras@med.navy.mil</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>James A Haley VA Hospital and Polytrauma Facility</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Stephen G Scott, DO</last_name>
      <phone>813-972-7506</phone>
      <email>steven.scott@va.gov</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ireland Army Community Hospital</name>
      <address>
        <city>Fort Knox</city>
        <state>Kentucky</state>
        <zip>40121</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kevin W Roberts</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ihi.org/IHI/Programs/Campaign/ADEsMedReconciliation.htm</url>
    <description>Institute for healthcare improvement &quot;Preventing adverse drug events&quot; Retrieved June 22, 2009</description>
  </link>
  <link>
    <url>http://www.talkaboutrx.org/documents/enhancing_prescription_medicine_adherence.pdf</url>
    <description>National Council on Patient Information and Education. (2008). &quot;Public policy &amp; adherence.&quot; Retrieved July 20, 2008</description>
  </link>
  <reference>
    <citation>Bates DW. Preventing medication errors: a summary. Am J Health Syst Pharm. 2007 Jul 15;64(14 Suppl 9):S3-9; quiz S24-6. Erratum in: Am J Health Syst Pharm. 2007 Aug 15;64(16):1678.</citation>
    <PMID>17617512</PMID>
  </reference>
  <reference>
    <citation>Cantor JB, Ashman T, Gordon W, Ginsberg A, Engmann C, Egan M, Spielman L, Dijkers M, Flanagan S. Fatigue after traumatic brain injury and its impact on participation and quality of life. J Head Trauma Rehabil. 2008 Jan-Feb;23(1):41-51. doi: 10.1097/01.HTR.0000308720.70288.af.</citation>
    <PMID>18219234</PMID>
  </reference>
  <reference>
    <citation>Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9.</citation>
    <PMID>11297331</PMID>
  </reference>
  <reference>
    <citation>Folstein MF, Folstein SE, McHugh PR. &quot;Mini-mental state&quot;. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98.</citation>
    <PMID>1202204</PMID>
  </reference>
  <reference>
    <citation>Hoge CW, Castro CA, Messer SC, McGurk D, Cotting DI, Koffman RL. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. N Engl J Med. 2004 Jul 1;351(1):13-22.</citation>
    <PMID>15229303</PMID>
  </reference>
  <reference>
    <citation>Institute for Healthcare Improvement. (2009). Prevent adverse drug events (medication reconciliation).</citation>
  </reference>
  <reference>
    <citation>Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009 Jan;15(1):59-66.</citation>
    <PMID>19146365</PMID>
  </reference>
  <reference>
    <citation>Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA. 2006 Dec 6;296(21):2563-71. Epub 2006 Nov 13.</citation>
    <PMID>17101639</PMID>
  </reference>
  <reference>
    <citation>McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA. 2002 Dec 11;288(22):2868-79. Review. Erratum in: JAMA. 2003 Jun 25;289(24):3242.</citation>
    <PMID>12472329</PMID>
  </reference>
  <reference>
    <citation>Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987 Aug;30(2):191-7.</citation>
    <PMID>3670870</PMID>
  </reference>
  <reference>
    <citation>Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008 May;10(5):348-54.</citation>
    <PMID>18453793</PMID>
  </reference>
  <reference>
    <citation>Nathan A, Goodyer L, Lovejoy A, Rashid A. 'Brown bag' medication reviews as a means of optimizing patients' use of medication and of identifying potential clinical problems. Fam Pract. 1999 Jun;16(3):278-82.</citation>
    <PMID>10439982</PMID>
  </reference>
  <reference>
    <citation>O'Connor PJ. Improving medication adherence: challenges for physicians, payers, and policy makers. Arch Intern Med. 2006 Sep 25;166(17):1802-4.</citation>
    <PMID>17000934</PMID>
  </reference>
  <reference>
    <citation>Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 Aug 4;353(5):487-97. Review.</citation>
    <PMID>16079372</PMID>
  </reference>
  <reference>
    <citation>Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky Medication Adherence Scale in patients with type 2 diabetes. Ann Pharmacother. 2009 May;43(5):950-7. doi: 10.1345/aph.1L453. Epub 2009 Apr 14.</citation>
    <PMID>19366872</PMID>
  </reference>
  <reference>
    <citation>Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999 Jun;37(2):113-24.</citation>
    <PMID>14528539</PMID>
  </reference>
  <reference>
    <citation>Touchette DR, Burns AL, Bough MA, Blackburn JC. Survey of medication therapy management programs under Medicare part D. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):683-91.</citation>
    <PMID>17176683</PMID>
  </reference>
  <reference>
    <citation>van Mil JW, Westerlund LO, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother. 2004 May;38(5):859-67. Epub 2004 Mar 30. Review.</citation>
    <PMID>15054145</PMID>
  </reference>
  <reference>
    <citation>Vasterling JJ, Proctor SP, Amoroso P, Kane R, Heeren T, White RF. Neuropsychological outcomes of army personnel following deployment to the Iraq war. JAMA. 2006 Aug 2;296(5):519-29.</citation>
    <PMID>16882958</PMID>
  </reference>
  <reference>
    <citation>Institute for Healthcare Improvement. (2009).</citation>
  </reference>
  <reference>
    <citation>Burkhart PV, Sabat√© E. Adherence to long-term therapies: evidence for action. J Nurs Scholarsh. 2003;35(3):207.</citation>
    <PMID>14562485</PMID>
  </reference>
  <reference>
    <citation>McNair, D., M. Lorr, et al. (1992). POMS Manual</citation>
  </reference>
  <reference>
    <citation>National Council on Patient Information and Education. (2008).</citation>
  </reference>
  <reference>
    <citation>Ware, J. E., K. K. Snow, et al. (1993). SF36 health survey: Manual and interpretation guide. Boston. MA, New England Medical Center</citation>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2009</study_first_submitted>
  <study_first_submitted_qc>November 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2009</study_first_posted>
  <last_update_submitted>November 3, 2009</last_update_submitted>
  <last_update_submitted_qc>November 3, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 4, 2009</last_update_posted>
  <responsible_party>
    <name_title>Daniel R.Touchette</name_title>
    <organization>University of Illinois at Chicago</organization>
  </responsible_party>
  <keyword>Telepharmacy Robotic Medicine Delivery Unit</keyword>
  <keyword>Brain Injuries</keyword>
  <keyword>Stress Disorders</keyword>
  <keyword>Combat disorders</keyword>
  <keyword>Polytrauma</keyword>
  <keyword>Adherence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Brain Injuries, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
    <mesh_term>Combat Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

